Related by context. All words. (Click for frequent words.) 72 ONGLYZA ™ 70 Investigational Drug 70 Treated Patients 70 Psoriasis Drug 69 Glatiramer Acetate 69 PDUFA Date 69 Schizophrenia Drug 69 Investigational Compound 69 Generic Versions 69 Generic Version 69 Phase 2b Study 68 Positive Opinion 68 Gout Drug 68 Demonstrated Significant 68 rasagiline tablets 68 Inhaled Insulin 68 Epilepsy Drug 68 Shows Efficacy 68 Cholesterol Lowering Drug 68 Oral Fingolimod 68 Receives Positive Opinion 68 Fondaparinux 67 Osteoporosis Drug 67 Investigational Agent 67 FDA Approvals 67 Lung Cancer Drug 67 Arthritis Drug 67 TYKERB 67 Cholesterol Drug 67 Testosterone Gel 67 Meets Primary Endpoint 67 Rotavirus Vaccine 67 Hepatitis C Treatment 67 Expanded Indication 67 Phase III Trials 67 Lupus Drug 67 Rheumatoid Arthritis Drug 67 Phase IIb Trial 67 Phase 2a Trial 67 Pooled Analysis 66 Capsules CII 66 Mylan Receives Approval 66 ACE Inhibitors 66 Raptiva ® 66 Erectile Dysfunction Drug 66 Betaferon R 66 Migraine Drug 66 Montelukast 66 Peginterferon Alfa 2a 66 STELARA TM 66 Prostate Cancer Vaccine 66 Prolongs Survival 66 Cimzia certolizumab pegol 66 Long Term Efficacy 66 NDA Submission 66 Diabetic Nephropathy 66 Teva Provides Update 66 Severe Sepsis 66 Raptiva R 66 FDA Accepts 66 Treatment Naive Patients 66 Romiplostim 66 Investigational Treatment 66 CIMZIA TM 65 Statin Drugs 65 Showed Significant 65 Combination Treatment 65 Confirmatory Phase 65 Osteoporosis Treatment 65 Valsartan 65 Schizophrenia Treatment 65 Febuxostat 65 Phase 2b Clinical Trial 65 AZILECT R 65 Moxifloxacin 65 Intravenous Formulation 65 Advanced Colorectal Cancer 65 Drug Candidate 65 Release Capsules 65 alfa 2a 65 Adjuvant Treatment 65 Lubiprostone 65 Fungal Infections 65 Blood Pressure Drug 65 Weight Loss Drug 65 Bevacizumab 65 Atypical Antipsychotics 65 Improved Survival 65 Heartburn Drugs 65 Anticancer Activity 65 HCV Protease Inhibitor 65 Amlodipine Besylate 65 Kidney Transplant Patients 65 Patients Treated With 65 ANDA Filing 65 Improves Survival 65 adalimumab Humira 65 Anemia Drug 65 rosuvastatin calcium 65 Demonstrates Significant 65 Pivotal Phase III 64 Fast Track Status 64 Granted Orphan Drug 64 Venous Thromboembolism 64 Tigecycline 64 Hepatitis B Vaccine 64 Pirfenidone 64 Release Tablets 64 Appears Safe 64 Rheumatoid Arthritis Patients 64 First Patient Enrolled 64 Clinical Trial Results 64 Insulin Glargine 64 atazanavir sulfate 64 NOXAFIL 64 Xyzal R 64 Oral Cladribine 64 Tipranavir 64 Double Blind Randomized 64 Phase III Clinical Trials 64 Medoxomil 64 mg Tablets 64 PROMACTA 64 Milestone Payment 64 Drug Fails 64 Pulmonary Arterial Hypertension 64 Colorectal Cancer Patients 64 Milestone Payments 64 Phase III Clinical Trial 64 FDA Okays 64 Antitumor Activity 64 Demonstrates Efficacy 64 Statistically Significant 64 Extended Release 64 vildagliptin 64 Liver Failure 64 Adjunctive Therapy 64 Newly Diagnosed Multiple Myeloma 64 Taro Receives 64 Relapsing Multiple Sclerosis 64 1mg 2mg 64 Advanced Prostate Cancer 64 Demonstrates Potent 64 Submits NDA 64 Generic Version Of 64 Prostate Cancer Patients 64 Treatment Regimen 64 See CLINICAL PHARMACOLOGY 64 Antidepressant Drug 64 Sitagliptin 64 Survival Benefit 64 Eltrombopag 64 Glufosfamide 64 R pioglitazone HCl 64 Breast Cancer Recurrence 64 JAK Inhibitor 64 Orapred ODT 64 ORENCIA ® 64 Pneumococcal Vaccine 64 SYCREST 64 Study Showed 64 BARACLUDE R 64 aripiprazole Abilify 64 Previously Treated 64 Epoetin Alfa 64 Initiate Clinical Trial 64 Demonstrate Significant 63 Hormone Refractory Prostate Cancer 63 Osteoarthritis Pain 63 Bosutinib 63 Patients Receiving 63 #mg Tablets [002] 63 Mirapexin 63 Advanced Melanoma 63 Pravastatin 63 Completes Patient Enrollment 63 Ropinirole 63 ORENCIA R 63 Ranolazine 63 Treatment Experienced 63 Phase III Trial 63 Pioglitazone 63 IND Application 63 Cardiovascular Outcomes 63 FDA APPROVES 63 Initiates Phase III 63 Files Investigational 63 Data Suggest 63 Novel Mechanism 63 Ecallantide 63 Patient Enrollment 63 Nicotine Vaccine 63 Vildagliptin 63 Phase 1b Clinical Trial 63 Single Dose 63 Pafuramidine 63 Drug Coated Stent 63 Double Blind Placebo 63 Darbepoetin Alfa 63 Patient Enrolment 63 ARIXTRA R 63 Chronic Hepatitis B 63 SPRYCEL ® 63 Clinical Trial Data 63 Is Well Tolerated 63 Hsp# Inhibitor 63 Seasonal Influenza Vaccine 63 Orphan Designation 63 Elderly Patients 63 Mycamine 63 Advanced Renal Cell 63 Marketing Authorisation 63 Receives Marketing Authorization 63 Sprycel dasatinib 63 Mg Usa 63 Ambrisentan 63 Patients Treated 63 Adjuvant Chemotherapy 63 Anti Nausea 63 Extended Release Tablets 63 Initiated Phase 63 Demonstrates Positive 63 Xyrem ® 63 Receives Orphan Drug Designation 63 Artery Disease 63 Multiple Myeloma Patients 63 Stronger Warnings 63 Clinical Trial Evaluating 63 ® pioglitazone HCl 63 Tiotropium 63 FASLODEX 63 Remicade infliximab 63 Calcium Acetate 63 Files IND 63 Versus Placebo 63 Relapsing Remitting Multiple Sclerosis 63 R lenalidomide 63 Phase 2a Clinical Trial 63 Announces Tentative Approval 63 Combo Therapy 63 Adalimumab 63 Present Preclinical Data 63 IRESSA 63 Dose Escalation 63 Controlled Study 63 GATTEX TM 63 Hepatitis C Genotype 62 Stem Cell Treatments 62 Phase 2b Trial 62 Successfully Completes Phase 62 Metformin HCl 62 Multicenter Trial 62 Anti Clotting Drug 62 Ticagrelor 62 GW# [003] 62 Parathyroid Hormone 62 Study Evaluates 62 Blood Thinner 62 Acute Heart Failure 62 Controlled Trial 62 BRILINTA 62 AVASTIN 62 Severe Asthma 62 Anticoagulant 62 Pazopanib 62 ONGLYZA 62 Oral Solution 62 PRIALT 62 RhuDex 62 Entecavir 62 Topline Results 62 Mirapexin R 62 ARCOXIA 62 Inhaled Corticosteroids 62 Fulvestrant 62 Slow Progression 62 BARACLUDE ® 62 Eszopiclone 62 Golimumab 62 TYGACIL 62 Glucophage XR 62 Actonel risedronate 62 Million Milestone Payment 62 Generic Protonix 62 Hypercholesterolemia 62 Levoleucovorin 62 Randomized Double Blind 62 Candesartan 62 pioglitazone HCl 62 Drug Shows Promise 62 Hematological Malignancies 62 Study Evaluating 62 Tuberculosis Vaccine 62 Randomized Controlled Trials 62 Inhalation Solution 62 Peginterferon alfa 2b 62 Drug Approvals 62 Tenormin 62 Dasatinib 62 Posaconazole 62 Neoadjuvant Chemotherapy 62 Rivaroxaban 62 rilonacept 62 Lung Cancer Patients 62 Transdermal Patch 62 Salmeterol 62 Tezampanel 62 Sensipar R 62 Prospective Randomized 62 Anti Tumor 62 Brentuximab Vedotin SGN 62 Certolizumab 62 Treat Anemia 62 Chronic Constipation 62 Gleevec Glivec 62 Dexilant 62 Castration Resistant Prostate Cancer 62 Renal Cell Carcinoma 62 Phase Ib Clinical Trial 62 Subgroup Analysis 62 Darunavir 62 Randomized Phase 62 Itraconazole 62 Antipsychotic Drug 62 Testosterone Patch 62 Protease Inhibitor 62 Clinical Outcome 62 ABILIFY R 62 Vaccine Adjuvant 62 REYATAZ ® 62 Unfractionated Heparin 62 Maleate 62 Faropenem 62 Orally Active 62 Trodusquemine MSI 62 Arimidex anastrozole 62 PEGASYS ® 62 interferon gamma 1b 62 Lotensin 62 Peginterferon 62 Dabigatran etexilate 62 Esbriet ® 62 Anemia Drugs 62 CIMZIA TM certolizumab pegol 62 Demonstrates Sustained 62 Bristol Myers Squibb Pravachol 62 Celebrex celecoxib 62 Hepatocellular Carcinoma 62 Initiate Phase 62 Antiplatelet Therapy 61 pioglitazone hydrochloride 61 Tasigna nilotinib 61 Improves Outcomes 61 Gastric Cancer 61 HFA MDI 61 IND Filing 61 Overactive Bladder 61 Heterozygous Familial Hypercholesterolemia 61 CAELYX 61 Psoriasis Patients 61 Mycophenolate Mofetil 61 Sodium Injection 61 Antiplatelet 61 Clinical Efficacy 61 Levofloxacin 61 Improve Survival 61 Antiepileptic Drug 61 CLARITY TIMI 61 Tablets #mg [002] 61 Pivotal Study 61 Diabetic Neuropathy 61 sorafenib tablets 61 Pivotal Trial 61 Preclinical Data 61 Inflammatory Markers 61 Metastatic Colorectal Cancer 61 Recombinant Human 61 INFERGEN 61 Mg Uk 61 metformin HCl 61 Topical Gel 61 Monotherapy 61 Randomized Trials 61 Supplemental Biologics License Application 61 Generic Equivalent 61 Aztreonam Lysine 61 REYATAZ R 61 colesevelam HCl 61 Orally Disintegrating Tablets 61 FDA Approvable Letter 61 Lung Cancer Trial 61 INSPIRE Trial Phase III 61 XGEVA 61 Orthostatic Hypotension 61 Drug Combo 61 FDA Approves Generic 61 FDA Panel Recommends 61 LENALIDOMIDE 61 Trobalt 61 Treatment Naïve 61 Pivotal Phase 61 Pharmacokinetic Study 61 Treatment Reduces 61 Teriparatide 61 Lanthanum Carbonate 61 GRAS Status 61 Orphan Drug Status 61 Toremifene 61 Tesamorelin 61 AstraZeneca Symbicort 61 Disease Modifying 61 Angiox ® 61 SEROQUEL XR 61 Dose Ranging Study 61 Sevelamer 61 Interferon Alfa 61 Ciclesonide 61 Receives Approvable Letter 61 Arthritis Drugs 61 PEGylated anti 61 Anticancer Drug 61 Initiates Enrollment 61 Metabolic Disorder 61 Pivotal Trials 61 Novel Therapies 61 Aflibercept 61 Combination Therapy 61 Cervical Cancer Vaccine 61 naproxen esomeprazole magnesium 61 Ixempra 61 Gene Therapy Trial 61 Patient Outcomes 61 Receives Orphan Drug 61 Nymox NX 61 Clinical Trial Enrollment 61 Novel Oral 61 Amgen Nplate 61 Carbidopa Levodopa 61 Desvenlafaxine 61 Cimzia ® 61 Pravachol pravastatin 61 Combination REOLYSIN R 61 Hydralazine 61 Estrogen Therapy 61 Afinitor everolimus 61 Resistant Hypertension 61 TO AVOID PREGNANCY WHILE 61 FOLOTYN ® 61 OMP designation 61 Postmenopausal Women 61 Safinamide 61 CHMP Opinion 61 Aliskiren 61 Tablet Formulation 61 Receives Complete Response 61 Pfizer Revatio 61 Synthetic Peptide 61 Neulasta ® 61 Dupuytren Contracture 61 JAK2 Inhibitor 61 Fluconazole 61 Protease Inhibitors 61 Effectively Treats 61 Roche Actemra 61 balsalazide disodium Capsules 61 Phase III Pivotal Trial 61 Frova R 60 Patients Enrolled 60 Clinical Guideline 60 Therapy Improves 60 Pegylated Interferon 60 Telmisartan 60 Angiogenic 60 Asacol R 60 Postmenopausal Osteoporosis 60 Accelerated Approval 60 Novel Inhibitor 60 Hospital Acquired Pneumonia 60 Rosiglitazone 60 Respiratory Distress 60 COLAZAL R 60 Stem Cell Treatment 60 Chronic Hepatitis C 60 Pfizer Sutent 60 Carvedilol 60 Anti Tumor Activity 60 Neupro R 60 Meta Analysis 60 Fabry Disease 60 Wyeth Torisel 60 KOMBIGLYZE XR 60 Noxafil 60 Bipolar Depression 60 Phase IIb Clinical Trial 60 Divalproex Sodium 60 Pertuzumab 60 Dalbavancin 60 Brilique 60 Diabetic Patients 60 ACE Inhibitor 60 Telithromycin 60 Indacaterol 60 Novel Therapeutic 60 6R BH4 60 Complicated Skin 60 balsalazide tablet 60 Boceprevir 60 Tesmilifene 60 Romidepsin 60 MAXALT 60 Node Positive 60 indiplon capsules 60 Zoledronic Acid 60 Well Tolerated 60 Dose Ranging 60 Pain Relievers 60 Multiple Ascending Dose 60 Confirms Patent 60 SmPC 60 RAPAFLO 60 inhalation aerosol 60 ACTEMRA TM 60 Efficacy Results 60 Marketing Authorization Applications 60 Ramelteon 60 Trial Evaluating 60 Serdolect ® 60 Kidney Transplant Recipients 60 Ziprasidone 60 Biologic License Application 60 RAPTIVA 60 CCX# B 60 Kepivance 60 Invasive Breast Cancer 60 Keryx Biopharma 60 Migraine Treatment 60 Asthma Treatment 60 Oral Laquinimod 60 PEG IFN 60 Vidaza azacitidine 60 Marketing Authorisation Application 60 Amrubicin 60 Nexavar ® 60 Cimzia TM 60 JANUVIA 60 Anticancer Drugs 60 Simulect 60 Teysuno 60 Sipuleucel T 60 acyclovir Lauriad R 60 Etanercept 60 GlaxoSmithKline plc GSK 60 Clostridium difficile Infection 60 Shingles Vaccine 60 Knee Osteoarthritis 60 Orphan Status 60 sertraline Zoloft 60 Allergic Rhinitis 60 Plaque Psoriasis 60 etanercept Enbrel 60 Pediatric Exclusivity 60 Aceon 60 Stent Placement 60 Cognitive Impairment 60 PRN FDA Approves 60 ULORIC 60 Zegerid OTC 60 Dapagliflozin 60 Fluticasone 60 Oral Calcitonin 60 Potent Antiviral Activity 60 Betaferon ® 60 Hemodialysis Patients 60 Stent Implantation 60 Cimzia ® certolizumab pegol 60 Treat Heart Failure 60 Rosuvastatin 60 Low Dose 60 ezogabine 60 Interferon beta 1a 60 Symptom Relief 60 Risedronate 60 Azacitidine 60 Zarnestra 60 Oral Insulin 60 Bucindolol 60 BYETTA ® 60 Lilly Cymbalta 60 AVANDIA 60 AMRIX 60 liposome injection 60 Launches Generic Version 60 Approvable 60 Alvesco ® 60 Placebo Controlled Study 60 Denufosol 60 Randomized Study 60 Treating Heart Failure 60 Fixed Dose 60 Silodosin 60 Muraglitazar 60 Tanespimycin 60 #mg #mg #mg [003] 60 Roche MabThera 60 VIVUS Announces 60 Lansoprazole 60 Acne Drug 60 PROCRIT R 60 Platelet Inhibition 60 dual endothelin receptor antagonist 60 APTIVUS 60 Drug Interactions 60 Catena ® 60 Stent Thrombosis 60 Recommends Approval 60 Initiates Clinical Trial 60 oral antidiabetic medication 60 Myelodysplastic Syndromes 60 oral salmon calcitonin 60 TORISEL TM 60 Treatment Regimens 60 Newly Diagnosed Patients 60 Emerging Therapies 60 Catapres 60 Prescription Medications 60 Zorbtive TM 60 PENTASA 60 prucalopride 60 Immunosuppressant 60 SIMCOR 60 Topiramate 60 Interferon beta 1b 60 Heart Failure Patients 60 Autologous Stem Cell Transplantation 59 Renal Cancer 59 Preclinical Models 59 Emollient Foam 59 candesartan cilexetil 59 Antiviral Therapy 59 Diamyd Medical Diamyd 59 Pharmacokinetics PK 59 Hematopoietic Stem Cell Transplantation 59 AEGR 59 Pemetrexed 59 Clofarabine 59 Randomized Clinical Trial 59 ARIXTRA 59 Alvesco R 59 HCV Genotype 59 Avastin bevacizumab 59 PEGINTRON TM 59 Phase IIa Clinical Trial 59 Randomized Clinical Trials 59 UCB Keppra 59 Inhalation Aerosol 59 Epratuzumab 59 FIRAZYR 59 Treating Chronic 59 EMEND 59 SHIRE PLC 59 CIMZIA ™ 59 Newly Diagnosed 59 TEMODAL 59 efalizumab 59 Welchol 59 bosentan Tracleer 59 Zenvia Phase III 59 Diet Pill 59 AstraZeneca Nexium 59 BioMarin Pharma 59 REMINYL ® 59 ISENTRESS 59 risedronate sodium tablets 59 Therapeutic Efficacy 59 Terbinafine 59 Immunogenicity 59 Proton Pump Inhibitors 59 Rotavirus Vaccines 59 Insulin Pen 59 DEXILANT 59 Advanced Ovarian Cancer 59 Infected Patients 59 PharmaVitae Profile 59 Ventavis 59 humanized interleukin 6 59 Shows Promising 59 Previously Untreated 59 Antipsychotic 59 Bayer Onyx 59 Vandetanib 59 Levaquin levofloxacin 59 Kidney Function 59 ATACAND 59 COPAXONE R 59 First Patient Treated 59 Pegylated Liposomal Doxorubicin 59 fostamatinib 59 Rebif ® 59 Preclinical Study 59 Torisel 59 HER2 Positive Breast Cancer 59 Everolimus 59 Etravirine 59 Patients Suffering 59 Integrase Inhibitor 59 Preterm Labor 59 Renal Function 59 Breast Cancer Treatment 59 Hedgehog Pathway 59 Pain Medications 59 Community Acquired Pneumonia 59 Ozarelix 59 alvimopan 59 Tamsulosin 59 rosiglitazone maleate 59 Disease Progression 59 RE LY 59 Bicalutamide 59 Didanosine 59 LIALDA 59 CTAP# Capsules 59 Investigational Drugs 59 Cutaneous T 59 Saquinavir 59 Genetically Engineered Salmon 59 Loceryl ® 59 Small Molecule Drug 59 Vidaza R 59 Product Designation 59 Doripenem 59 Sanctura XR 59 HoFH 59 Generic Lipitor 59 Lung Cancer Survival 59 Companion Diagnostic 59 Pivotal Phase II 59 Tylenol Recall 59 Pivotal Clinical Trial 59 Avandia Avandamet 59 TREDAPTIVE 59 SABER ™ 59 Contaminated Heparin 59 Percutaneous Tibial Nerve Stimulation 59 Recurrent Breast Cancer 59 sorafenib Nexavar 59 Frova ® 59 Immunosuppression 59 PROVIGIL 59 Bivalirudin 59 Prognostic Significance 59 LEVADEX ™ 59 Drug Maker 59 Antiviral Activity 59 Statin Therapy 59 Drug Coated Stents 59 II Clinical Trial 59 Aptivus 59 Liver Transplant Patients 59 Kidney Transplants 59 Boosts Survival 59 Cheap Generic 59 Anti infective 59 Sapacitabine 59 glatiramer acetate 59 Genetic Tests 59 Bayer Nexavar 59 icatibant 59 Icatibant 59 Hematological Cancers 59 Seroquel quetiapine 59 Gene Linked 59 DORIBAX 59 Tolvaptan 59 miconazole Lauriad ® 59 Lixisenatide 59 Blood Thinning 59 ZACTIMA 59 Valvular Heart Disease 59 Enoxaparin 59 Idiopathic Pulmonary Fibrosis 59 ALVESCO R 59 Phase IIIb 59 brivaracetam 59 Ceflatonin R 59 Hycamtin ® 59 entitled Formulary Advantages 59 Neuroendocrine Tumors 59 Acute Ischemic Stroke 59 MEZAVANT R 59 LEVAQUIN 59 methylnaltrexone bromide 59 Relapsed Refractory 59 rotigotine transdermal patch 59 Tracleer ® bosentan 59 Glybera R 59 Eli Lilly Zyprexa 59 Advagraf 59 Firazyr 59 Vfend 59 Archexin 59 esomeprazole Nexium 59 Certican 59 Pneumonia Vaccine 59 Pramipexole 59 Prostate Cancer Treatment 59 Ketorolac 59 Sycrest 59 PROCRIT ® 59 FULL PRESCRIBING INFORMATION 59 Initiate Phase II 59 Systemic Sclerosis 59 Kinase Inhibitor 59 Initiates Clinical 59 Clinical Trials Update 59 memantine HCl 59 Randomized Double blind 59 SEROQUEL R 59 Diabetic Macular Edema 59 solifenacin succinate 59 Adverse Event 59 sunitinib Sutent 59 Authorized Generic 59 eltrombopag 59 Tacrolimus 59 Marketing Authorization Application 59 Geodon ziprasidone 59 Ovarian Cancer Treatment 59 BARACLUDE r 59 Asthma COPD 59 Adjuvant Therapy 59 IIa Clinical Trial 59 febuxostat 59 sitagliptin metformin 59 Telaprevir VX 59 Transdermal Delivery 59 Ranexa R 59 C1 Inhibitor 59 Adenuric R 59 Therapeutic Vaccine 59 Product Monograph 59 Novel Antibiotic 59 Atazanavir 59 Marketing Authorization 59 Fludara ® 59 Hydrochlorothiazide 59 Placebo Controlled Trial 59 Nitazoxanide 59 Gene Variation 58 TB Vaccine 58 lexidronam injection 58 Nexium esomeprazole 58 Intervention Effectiveness 58 cinacalcet HCl 58 Chronic Lymphocytic Leukemia 58 AstraZeneca Toprol XL 58 Topiramate Tablets 58 Smallpox Vaccine 58 Mimpara 58 Galantamine 58 Metastatic Melanoma 58 Surgical Mesh 58 Guidelines Recommend 58 NPS NPS Pharmaceuticals 58 Neuroprotective Effects 58 Benign Prostatic Hyperplasia 58 Navelbine ® 58 Epidermal Growth Factor Receptor 58 Azathioprine 58 ziprasidone Geodon 58 Rilonacept 58 Prognostic Value 58 Malignant Melanoma 58 lacosamide 58 Inflammatory Arthritis 58 R# #mg BID 58 Shows Promise Against 58 Desvenlafaxine Succinate 58 FOSRENOL 58 Lenalidomide 58 Therapeutic Potential 58 FDA Approves Drug 58 Risperidone 58 azilsartan medoxomil 58 Roflumilast 58 Allogeneic 58 Earns Milestone Payment 58 Topical Treatment 58 Relapsed Multiple Myeloma 58 Actoplus Met 58 tocilizumab 58 Keppra ® XR 58 Levetiracetam Tablets 58 Hepatitis C Virus 58 Fixed Dose Combination 58 Stable Angina 58 Cilostazol 58 Biologic Therapy 58 rizatriptan 58 FDA Clears 58 vapreotide acetate 58 Lialda 58 Sanvar 58 Autoimmune Disease 58 Bazedoxifene 58 Initiates Clinical Trials 58 Oracea ® 58 Achieves Primary Endpoint 58 pitavastatin 58 YONDELIS 58 Cold Medicines 58 HER2 Positive 58 Liver Toxicity 58 Preotact R 58 Atopic Dermatitis 58 Receives CE Marking 58 Elagolix 58 Esbriet pirfenidone 58 Keppra ® levetiracetam 58 Product Characteristics 58 Linagliptin 58 Oxybutynin 58 Tekturna HCT 58 Veregen TM 58 Soriatane 58 Ramipril 58 Completes Enrollment 58 Femara letrozole 58 Arixtra ® 58 ZOMIG R 58 Advanced Pancreatic Cancer 58 Lowering Blood Pressure 58 Panzem R 58 #-# Full Text 58 tacrolimus capsules 58 Interferon Alpha 58 Paliperidone ER 58 phase IIIb 58 Renal Impairment 58 Nesiritide 58 Adefovir 58 Myoblast 58 Myeloma Patients 58 Drug Eluting Stent System 58 Ocrelizumab 58 Injection Site 58 Observational Study 58 abacavir sulfate lamivudine 58 sunitinib malate 58 RoACTEMRA 58 Submits Biologics License Application 58 Alkeran 58 Equetro 58 Podium Presentation 58 certolizumab pegol 58 CORDAPTIVE 58 FDA Warns Against 58 Late Breaker 58 peginterferon alfa 58 HDAC Inhibitor 58 Renal Anemia 58 Hormone Receptor Positive 58 Velcade bortezomib 58 Iloperidone 58 Brain Metastases 58 Myocardial Perfusion Imaging 58 fluoroquinolone antibiotic 58 Treating Depression 58 Unresectable 58 Azilect R 58 Keppra R 58 Bronchodilator 58 Chronic Cough 58 Increlex R 58 TNF Tumor Necrosis Factor 58 Hormone Therapy 58 Valganciclovir 58 Sumatriptan Succinate 58 Non Alcoholic Steatohepatitis 58 Chronic Inflammation 58 Cimzia R 58 sapropterin dihydrochloride 58 Lupus Nephritis 58 Prostate Screening 58 Fibromyalgia Pain 58 Torisel temsirolimus 58 Initiates Phase 2b 58 European Medicines Evaluation 58 LYSTEDA 58 Arch Neurol 58 Confirms Efficacy 58 Prevent Stroke 58 SUTENT ® 58 R darbepoetin alfa 58 Sanofi aventis EURONEXT SAN 58 Package Insert 58 Promacta 58 Contrast Agent 58 Influenza Vaccine 58 Therapeutic Antibody